Alzheimer’s blood tests may one day allow patients and their doctors to track their individual progress in reducing risk, ...

The correspondence of Gene Hackman and Betsy Arakawa was humorous, sad, moving and mundane, offering a glimpse into the ...

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms.

Ultrasound therapy is emerging as a potential treatment for Alzheimer’s disease. It uses ultrasound to open the blood-brain ...

It’s possible that they may play a role as a preventative measure in the future,” said Dr. Catriona Reddin told The Post.

Many people aren’t benefiting from the shingles vaccine now. Not only can it prevent shingles — it also may protect the brain ...

A research team at the Institute for Basic Science (IBS) has identified a previously unknown enzyme, SIRT2, that plays a key ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Leqembi approved by the EU for early-stage Alzheimer’s in patients with specific ApoE4 gene profile, marking a milestone in ...

Scientists Identify Key Enzyme in Alzheimer's Disease That Links Brain Inflammation to Memory Loss Apr. 14, 2025 — A research team has identified a previously unknown enzyme, SIRT2, that plays a ...

Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

Continued treatment with AXS-05, a combination of dextromethorphan and bupropion, significantly reduces the risk for recurrence of Alzheimer’s disease–related agitation, phase 3 results show.